Verona jumps after Merck's $10 billion acquisition

Verona Pharma

09/07/2025 12:00

Updates

** U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F jump 20.3% to $104.47 premarket

** Merck MRK.N will buy London-based Verona Pharma for about $10 billion

** Merck will pay $107 per American depository share for Verona

** The purchase price is a premium of about 23% to Verona ADS' last closing price

** The Financial Times first reported the deal on Wednesday

** Up to last close, stock up 87% YTD

 (Reporting by Christy Santhosh and Siddhi Mahatole)

 ((Christy.Santhosh@thomsonreuters.com))